CNW.F CO.DON AG INH. O.N.

Healthcare Biotechnology Frankfurt Exchange
0.0050 EUR
Close of Nov 6, 2026
0.0040 0.0200
Market cap
EUR 134K
P/E
-
P/B
0.16x
ROE
-53.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2021.

Is CNW.F undervalued?

Graham number

The Graham number of CO.DON AG INH. O.N. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CO.DON AG INH. O.N. fundamental analysis

No fundamental analysis for CO.DON AG INH. O.N. yet.

CO.DON AG INH. O.N. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CO.DON AG INH. O.N.

co.don AG does not have significant operations. Previously, the company was engaged in the development, production, and marketing of biopharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.

Full company profile